AVADEL PHARMACEUTICALS PLC's ticker is AVDL and the CUSIP is 05337M104. A total of 82 filers reported holding AVADEL PHARMACEUTICALS PLC in Q2 2020. The put-call ratio across all filers is 0.75 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $5,404,400 | +3963.5% | 590,000 | +6696.5% | 0.16% | +7900.0% |
| Q2 2020 | $133,000 | +75.0% | 8,681 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $76,000 | +15.2% | 8,681 | 0.0% | 0.00% | +100.0% |
| Q4 2019 | $66,000 | -99.3% | 8,681 | -99.3% | 0.00% | -99.6% |
| Q1 2018 | $9,447,000 | -51.8% | 1,295,841 | -45.8% | 0.26% | -59.2% |
| Q4 2017 | $19,613,000 | -39.7% | 2,391,841 | -22.8% | 0.65% | +4.7% |
| Q3 2017 | $32,530,000 | +106.4% | 3,098,010 | +116.8% | 0.62% | -21.7% |
| Q2 2017 | $15,763,000 | +15.6% | 1,429,114 | +1.5% | 0.79% | +2.1% |
| Q1 2017 | $13,632,000 | -5.5% | 1,408,240 | +1.4% | 0.78% | -24.3% |
| Q4 2016 | $14,424,000 | – | 1,388,240 | – | 1.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| WEALTH EFFECTS LLC | 2,498,838 | $22,889,355 | 11.72% |
| Knoll Capital Management, LLC | 500,000 | $4,580,000 | 7.06% |
| GENDELL JEFFREY L | 5,301,914 | $48,565,532 | 4.55% |
| COWEN AND COMPANY, LLC | 3,732,778 | $34,192,246 | 4.02% |
| Tri Locum Partners LP | 1,327,097 | $12,156,209 | 3.70% |
| Samsara BioCapital, LLC | 1,409,409 | $12,910,186 | 2.67% |
| Altium Capital Management LP | 500,000 | $4,580,000 | 2.54% |
| Vivo Capital, LLC | 3,761,438 | $34,454,772 | 2.39% |
| RTW INVESTMENTS, LP | 5,741,939 | $52,596,161 | 1.10% |
| Knott David M Jr | 291,113 | $2,667 | 1.05% |